ZIVO BIOSCIENCE INC
*W EXP 05/14/202 · CUSIP 98978N119
6
institutional holders
+0 vs Q1 2022
94.2k
shares reported held*
$62.0kreported value*
0 new
1 added
1 reduced
0 sold out
net sold ≈ $5.9k (-10.3k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.66.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2021 | 4 |
| Q3 2021 | 5 |
| Q4 2021 | 6 |
| Q1 2022 | 6 |
| Q2 2022 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2021 | 3 | 1 |
| Q4 2021 | 1 | 1 |
| Q1 2022 | 2 | 0 |
| Q2 2022 | 1 | 1 |
Biggest buyers
| UBS Group AG | Added | +300 |
Biggest sellers
| Warberg Asset Management LLC | Reduced | -10.6k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Ayrton Capital LLC 0.06% of their portfolio | 48.9k $36.0k | Unchanged |
| CVI Holdings, LLC 0.00% of their portfolio | 16.1k $11.0k | Unchanged |
| Warberg Asset Management LLC 0.00% of their portfolio | 15.6k $9.0k | Reduced -10.6k |
| Verdence Capital Advisors LLC 0.00% of their portfolio | 10.0k $4.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 3.6k $2.0k | Added +300 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |